COMPOUND RECORD / B-300

B-300

Research lead

Research profile — evidence review incomplete. Topic tags are research navigation, not indications or recommendations. Source access does not establish effectiveness or safety.

01 / OVERVIEW

What is it?

An experimental multi-ingredient formulation from Russian performance research, built around Bemitil and Trekrezan. It is not a single molecule and is distinct from Binavit.

Identity / background source ↗

Research context

Elistratov’s 2012 dissertation describes Bemitil/Metaprot plus Trekrezan formulations studied in operator and environmental-stress contexts. B-300 is not Binavit. The recap also names B2/B3 cofactors; exact composition and study-arm details need original methods verification.

Working classification: Experimental combination
Research collection: Actoprotection & occupational pharmacology · editorial grouping
Institutional provenance: Not established for this compound record
Last evidence review: Full evidence review pending; source-check scope appears with each publication below.

02 / EVIDENCE DIMENSIONS

What do we know?

Human research: —Not assessed
Study methods: —Not assessed
Independent replication: —Not assessed
Source access: —Not catalogued
Safety evidence: —Not assessed

These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.

03 / SOURCE TRAIL

Linked sources

Explore the research map and unresolved leads ↗

No study-level evidence has been entered for this profile. This does not mean no research exists.

Browse bibliography & PDFs ↗